Art Therapy and Its Effect on Non-Motor Function Rehabilitation in the Subacute Phase of Stroke Recovery
Launched by CHONBUK NATIONAL UNIVERSITY · Nov 27, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the effects of art therapy on stroke recovery, specifically focusing on helping patients improve their emotional, cognitive, and social functions during the subacute phase of recovery (which is 2 weeks to 3 months after a stroke). Stroke can lead to various challenges beyond just physical impairments, and traditional treatments don't always address these non-motor issues. Art therapy, which includes activities like painting, music, and dance, aims to help patients manage their emotions, reduce anxiety and depression, and support brain recovery, potentially leading to better overall rehabilitation.
To participate in this study, individuals must be between 40 and 75 years old and have experienced their first stroke within the last three months. They should have mild to moderate difficulties after the stroke but still be somewhat mobile and able to engage in simple art activities. Participants will be expected to attend regular therapy sessions and should have basic communication skills to express their thoughts and feelings during therapy. It’s important to note that those with severe mental health issues, serious physical illnesses, or recent participation in similar therapies will not be eligible. This trial offers a unique opportunity for stroke patients to potentially enhance their recovery through creative expression.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Study Participants: Stroke patients aged 40-75. Patients in this age group generally have a higher incidence of stroke and show relatively higher plasticity during the rehabilitation process.
- • 2. Type of Stroke: First occurrence of ischemic or hemorrhagic stroke, confirmed by imaging (CT or MRI). This helps to ensure consistency in the type of stroke among participants, reducing rehabilitation differences caused by varying stroke types.
- • 3. Time Since Stroke Onset: Between 2 weeks and 3 months post-stroke (broadly defined subacute phase). During this phase, patients have usually transitioned out of the acute treatment phase and exhibit significant plasticity in physical and psychological recovery, making it a critical period for rehabilitation.
- • 4. Severity of Stroke Sequelae: Stroke sequelae should be mild to moderate (Modified Rankin Scale score of 2 to 3). These patients have some level of independent mobility but still require rehabilitation training to further improve function.
- • 5. Cognitive Ability: Participants must have basic cognitive function and be able to understand and comply with research requirements. This ensures that patients can effectively participate in art therapy and accurately report subjective experiences.
- • 6. Emotional Status: Participants' levels of depression, anxiety, or stress should be mild to moderate at the start of the study. Patients with severe psychological disorders may require more intensive psychological support, which falls outside the scope of this study.
- • 7. Language and Communication Skills: Participants must possess basic language expression and comprehension abilities to engage in and understand interactions during art therapy sessions. This ensures effective communication with the therapist.
- • 8. Physical Condition: Participants must have the basic physical functions necessary to participate in art therapy, such as the ability to perform simple limb movements and activities. Severe physical disabilities may prevent participation in art activities.
- • 9. Living Environment: Participants should reside in an area that allows them to regularly travel to the treatment site and have a relatively stable living environment. This helps ensure that patients can attend each therapy session on time and complete the entire intervention cycle.
- • 10. Consent to Participate: Both the patient and their family members must fully understand the purpose, process, and potential risks of the study and be willing to sign an informed consent form. This ensures that patients fully comprehend their responsibilities and rights when participating in the study.
- • 11. No Prior Psychological or Art Therapy: Participants must not have received any form of psychological therapy, art therapy, or similar rehabilitation intervention in the past 6 months to exclude the impact of other interventions on the study results.
- Exclusion Criteria:
- • 1. Severe Mental Illness: A history or current diagnosis of severe mental disorders (e.g., schizophrenia, bipolar disorder) or a current severe level of depression, anxiety, or stress. These mental health issues may require specialized psychological treatment, which is not aligned with the intervention objectives of this study.
- • 2. Severe Comorbidities: Patients with serious physical illnesses, such as advanced cancer, severe heart disease (e.g., heart failure, acute coronary syndrome), chronic renal failure, or severe chronic respiratory diseases. These conditions may severely affect the patient's ability to participate and the rehabilitation outcomes.
- • 3. Severe Sensory Impairments: Patients with serious sensory impairments, such as blindness, profound hearing loss, or uncorrectable sensory deficits. These impairments may prevent effective participation in art therapy, especially in activities requiring visual or auditory engagement (such as painting or music therapy).
- • 4. Severe Language Impairments: Patients with severe aphasia or speech communication disorders that impede effective communication or expression. This would affect the patient's ability to participate in and understand the therapy process.
- • 5. Substance Dependence or Abuse History: Patients with a current history of substance dependence or abuse (including alcohol and illicit drugs). Such conditions may significantly impact cognitive and behavioral functions, potentially interfering with the study's intervention effects.
- • 6. Allergies or Physical Discomfort: Patients with severe allergic reactions to materials potentially used in art therapy (e.g., paint, clay, musical instruments) or a history of physical discomfort caused by similar materials.
- • 7. Lack of Willingness to Participate: Patients or their family members show insufficient willingness to participate in the study or are unable to provide written informed consent. This may lead to premature withdrawal, affecting the study's integrity and result analysis.
- • 8. Other Potential Influencing Factors: Any other factors not listed but considered by researchers to potentially affect patient participation or study outcomes. For example, significant life events (e.g., bereavement, divorce), which may have a considerable impact on the patient's psychological state.
About Chonbuk National University
Chonbuk National University (CBNU) is a leading academic institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on collaboration between medical professionals and researchers, CBNU aims to enhance patient outcomes and contribute to the global body of medical knowledge. The university's clinical trial programs focus on a wide range of therapeutic areas, leveraging cutting-edge technology and methodologies to ensure rigorous scientific standards and ethical practices. By fostering an environment of excellence and innovation, CBNU plays a pivotal role in the advancement of medical science and the development of new treatment modalities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jiamusi,, Heilongjiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported